Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 16
Exclusion Criteria
- Clinically significant allergy or sensitivity to medications Positive test for human immunodeficiency virus (HIV) antibodies, Hepatitis B surface antigen, or Hepatitis C antibody.
- Pregnant or breast feeding.
- History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
- ...
- Clinically significant allergy or sensitivity to medications Positive test for human immunodeficiency virus (HIV) antibodies, Hepatitis B surface antigen, or Hepatitis C antibody.
- Pregnant or breast feeding.
- History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
- Any disorder that may interfere with drug absorption.
- Clinically significant abnormalities on physical examination, medical history, ECG , vital signs, laboratory values, or unstable medical or psychiatric illness
Summary
- Conditions
- Healthy
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 50 years
- Gender
- Both males and females
Exclusion Criteria
- Clinically significant allergy or sensitivity to medications Positive test for human immunodeficiency virus (HIV) antibodies, Hepatitis B surface antigen, or Hepatitis C antibody.
- Pregnant or breast feeding.
- History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
- ...
- Clinically significant allergy or sensitivity to medications Positive test for human immunodeficiency virus (HIV) antibodies, Hepatitis B surface antigen, or Hepatitis C antibody.
- Pregnant or breast feeding.
- History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
- Any disorder that may interfere with drug absorption.
- Clinically significant abnormalities on physical examination, medical history, ECG , vital signs, laboratory values, or unstable medical or psychiatric illness
Tracking Information
- NCT #
- NCT02001389
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon